tirzepatide nafld Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic liver disease by reducing the expression of CD36 and OBP2A Consistent improvements in liver histology

This duo promotes protein synthesis, lean mass accrual, and recovery in the preconception period which can optimize BMR and fat loss

Optum Rx Weight Engage is a new solution that pairs GLP-1 medications with education and ongoing support to help people see better results and build lasting behavior change

Vitamin B 6 and fate of selenium for the control of the GSH-Px system Most of the reactions involved in the fate of organic selenium for the control of the GSH-Px system (Figure 4) are B6-dependent (Yasumoto et al., 1979)

Cardiovascular outcomes with tirzepatide: A metaanalysis of the SURPASS clinical trials

GLP-1 medications are not recommended during pregnancy, so plan with your provider if you are considering becoming pregnant

Cases J, Ibarra A, Feuillere N, Roller M, Sukkar SG